Clinical trials
Active, not recruiting Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 2 |
| Amgen | 1 |
| Children's Cancer Group, China | 1 |
| Institut de Recherches Internationales Servier (I.R.I.S.) | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Novartis Pharmaceuticals | 1 |
| Ruijin Hospital | 1 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Lymphoma, Non-Hodgkin | 2 |
| Recurrence | 2 |
| Burkitt Lymphoma | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma, B-Cell | 1 |
| Neoplasm, Residual | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.